Baroreflex sensitivity and heart rate variability in the identification ofpatients at risk for life-threatening arrhythmias - Implications for clinical trials
Mt. La Rovere et al., Baroreflex sensitivity and heart rate variability in the identification ofpatients at risk for life-threatening arrhythmias - Implications for clinical trials, CIRCULATION, 103(16), 2001, pp. 2072-2077
Citations number
21
Categorie Soggetti
Cardiovascular & Respiratory Systems","Cardiovascular & Hematology Research
Background-The need for accurate risk stratification is heightened by the e
xpanding indications for the implantable cardioverter defibrillator, The Mu
lticenter Automatic Defibrillator Implantation Trial (MADIT) focused intere
st on patients with both depressed left ventricular ejection fraction (LVEF
) and the presence of nonsustained ventricular tachycardia (NSVT), Meanwhil
e, the prospective study Autonomic Tone and Reflexes After Myocardial Infar
ction (ATRAMI) demonstrated that markers of reduced vagal activity, such as
depressed baroreflex sensitivity (BRS) and heart rate variability (HRV), a
re strong predictors of cardiac mortality after myocardial infarction.
Methods and Results We analyzed 1071 ATRAMI patients after myocardial infar
ction who had data on LVEF, 24-hour ECG recording, and BRS, During follow-u
p (21+/-8 months), 43 patients experienced cardiac death, 5 patients had ep
isodes of sustained VT, and 30 patients experienced sudden death and/or sus
tained VT. NSVT, depressed BRS, or HRV were all significantly and independe
ntly associated with increased mortality. The combination of all 3 risk fac
tors increased the risk of death by 22x, Among patients with LVEF<35%, desp
ite the absence of NSVT, depressed BRS predicted higher mortality (18% vers
us 4.6%, P=0.01). This is a clinically important finding because this group
constitutes 25% of all patients with depressed LVEF. For both cardiac and
arrhythmic mortality, the sensitivity of low BRS was higher than that of NS
VT and HRV.
Conclusions-BRS and HRV contribute importantly and additionally to risk str
atification. Particularly when LVEF is depressed, the analysis of BRS ident
ifies a large number of patients at high risk for cardiac and arrhythmic mo
rtality who might benefit from implantable cardioverter defibrillator thera
py without disproportionately increasing the number of false-positives.